These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20932483

  • 21. [The HIV pandemic in the year 2007, an overview].
    Bartelsman M, Veeken H.
    Ned Tijdschr Geneeskd; 2007 Dec 01; 151(48):2655-60. PubMed ID: 18179081
    [Abstract] [Full Text] [Related]

  • 22. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
    Lederman MM, Offord RE, Hartley O.
    Nat Rev Immunol; 2006 May 01; 6(5):371-82. PubMed ID: 16639430
    [Abstract] [Full Text] [Related]

  • 23. The future of microbicides.
    Omar RF, Bergeron MG.
    Int J Infect Dis; 2011 Oct 01; 15(10):e656-60. PubMed ID: 21705253
    [Abstract] [Full Text] [Related]

  • 24. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML, Cwiak CA, Koudelka C, Jensen JT.
    Contraception; 2007 Oct 01; 76(4):314-8. PubMed ID: 17900444
    [Abstract] [Full Text] [Related]

  • 25. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A.
    Ethiop Med J; 2006 Oct 01; 44(4):405-15. PubMed ID: 17370443
    [Abstract] [Full Text] [Related]

  • 26. Intravaginal and intrarectal microbicides to prevent HIV infection.
    Balzarini J, Van Damme L.
    CMAJ; 2005 Feb 15; 172(4):461-4. PubMed ID: 15710933
    [No Abstract] [Full Text] [Related]

  • 27. [Vaginal virucides against HIV].
    Stone AB.
    Gynecol Obstet Fertil; 2004 Feb 15; 32(7-8):638-45. PubMed ID: 15450263
    [Abstract] [Full Text] [Related]

  • 28. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH.
    AIDS; 2006 Jul 13; 20(11):1551-3. PubMed ID: 16847411
    [Abstract] [Full Text] [Related]

  • 29. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR.
    Antiviral Res; 2010 Dec 13; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [Abstract] [Full Text] [Related]

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 13; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 31. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK, Vanham G.
    Future Microbiol; 2010 Nov 13; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract] [Full Text] [Related]

  • 32. Women's interest in vaginal microbicides.
    Darroch JE, Frost JJ.
    Fam Plann Perspect; 1999 Nov 13; 31(1):16-23. PubMed ID: 10029928
    [Abstract] [Full Text] [Related]

  • 33. Update on microbicide research and development - seeking new HIV prevention tools for women.
    Mertenskoetter T, Kaptur PE.
    Eur J Med Res; 2011 Jan 27; 16(1):1-6. PubMed ID: 21345763
    [Abstract] [Full Text] [Related]

  • 34. The future of HIV microbicides: challenges and opportunities.
    Garg AB, Nuttall J, Romano J.
    Antivir Chem Chemother; 2009 Jan 27; 19(4):143-50. PubMed ID: 19374141
    [Abstract] [Full Text] [Related]

  • 35. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul 27; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 36. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.
    Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE.
    HIV Med; 2010 Apr 27; 11(4):282-8. PubMed ID: 20015220
    [Abstract] [Full Text] [Related]

  • 37. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, PharmAccess African Studies to Evaluate Resistance Programme.
    Antivir Ther; 2008 Apr 27; 13(5):625-39. PubMed ID: 18771046
    [Abstract] [Full Text] [Related]

  • 38. Microbicides: a new frontier in HIV prevention.
    McGowan I.
    Biologicals; 2006 Dec 27; 34(4):241-55. PubMed ID: 17097303
    [Abstract] [Full Text] [Related]

  • 39. Microbicides. Raising new barriers against HIV infection.
    Trager RS.
    Science; 2003 Jan 03; 299(5603):39. PubMed ID: 12511630
    [No Abstract] [Full Text] [Related]

  • 40. After microbicide failures, hope that antiviral approach will gel.
    Padma TV.
    Nat Med; 2008 Apr 03; 14(4):354. PubMed ID: 18391925
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.